Lymph node surgery study for certain early endometrial cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial studies whether adding lymph node removal (lymphadenectomy) during surgery helps people with certain early-stage endometrial cancer. It focuses on patients who do not have visibly enlarged lymph nodes and who can safely have the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed endometrial cancer and it fits specific early-stage groups (T1a G3, T1b, or T2) based on your biopsy
- You have not had prior cancer surgery for endometrial cancer, or you had certain additional surgery within 8 weeks after hysterectomy only if no lymph node surgery was done
- Your scans/exam show no large (bulky) lymph nodes
- You are generally well enough for surgery (ECOG 0–1) and between ages 18 and 75
- You have no prior chemotherapy, radiation, or hormone (endocrine) treatment for endometrial cancer
- You can safely have surgery, including lymph node removal, and can follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial compares two ways to remove lymph nodes during hysterectomy for endometrial cancer that hasn't spread. The goal is to find which method works better with similar or fewer side effects.
This trial tests a “sentinel node” biopsy, using a special dye/tracer, during surgery for early-stage endometrial cancer. It may help doctors find whether cancer has spread to lymph nodes while possibly avoiding more extensive lymph node removal.
This study looks at women with low-risk endometrial cancer who had tiny amounts of cancer cells found in their sentinel lymph nodes during surgery. Doctors want to see if it's safe to avoid additional treatments like chemotherapy or radiation.
This trial studies whether removing (dissecting) lymph nodes during surgery can improve care for people with early-stage ovarian cancer that still needs chemotherapy. You may be eligible if you have certain ovarian cancer types and your scans and surgery do not show clearly suspicious lymph nodes.
Hear when a new Cancer of Endometrium Stage I trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.